GlassScriptPhysician profile
Natalie G Beemer
NPI 1700217726
$8,200.14
in general payments reported to CMS, 2019-2025
16 companies · $4,269 in 2025
The $4,269 reported for 2025 was more than what 98% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $124 · 2023: $1,917 · 2024: $1,890 · 2025: $4,269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,937 · Education: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,936.92 |
| Education | $138.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,357.51 | 2023-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,189.40 | 2023-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $1,130.96 | 2023-2025 | Austedo Xr, Austedo, Austedo Xr |
| Axsome Therapeutics, INC. | $1,093.59 | 2023-2025 | Auvelity, Sunosi |
| Alkermes, INC. | $829.05 | 2022-2025 | Aristada, Lybalvi |
| Otsuka America Pharmaceutical, INC. | $783.26 | 2022-2025 | Rexulti, Nuedexta |
| Corium, LLC | $431.76 | 2023-2025 | Azstarys |
| Lundbeck LLC | $326.04 | 2024-2025 | Rexulti |
| Tris Pharma INC | $320.11 | 2023-2025 | Dyanavel Xr, Quillichew Er, Quillivant |
| Vanda Pharmaceuticals INC. | $188.86 | 2025 | Fanapt |
| Janssen Pharmaceuticals, INC | $159.54 | 2025 | Spravato |
| Takeda Pharmaceuticals U.S.A., INC. | $153.79 | 2024-2025 | Trintellix |
| Neuronetics, INC. | $116.24 | 2023-2025 | Neurostar Tms Therapy System |
| E.R. Squibb & Sons, L.L.C. | $73.69 | 2024 | Cobenfy |
| Neos Therapeutics, LP | $30.29 | 2024 | Adzenys Xr-Odt |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $16.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Beemer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.